| Index | — | P/E | 6.49 | EPS (ttm) | 4.01 | Insider Own | — | Shs Outstand | 116.17M | Perf Week | 0.93% |
| Market Cap | 3.02B | Forward P/E | 9.35 | EPS next Y | 2.78 | Insider Trans | 0.00% | Shs Float | 101.86M | Perf Month | 6.51% |
| Enterprise Value | 2.96B | PEG | 1.01 | EPS next Q | 0.64 | Short Float | 5.48% | Perf Quarter | 8.69% | ||
| Income | 506.00M | P/S | 0.93 | EPS this Y | 7.61% | Short Ratio | 6.96 | Perf Half Y | 14.23% | ||
| Sales | 3.25B | P/B | 1.33 | EPS next Y | 4.99% | ROA | 4.00% | Short Interest | 5.58M | Perf YTD | 18.82% |
| Book/sh | 19.60 | P/C | 0.51 | EPS next 5Y | 6.40% | ROE | 21.84% | 52W High | 26.50 -1.96% | Perf Year | 42.99% |
| Cash/sh | 50.82 | P/FCF | 12.38 | EPS past 3/5Y | — 18.99% | ROIC | -113.08% | 52W Low | 17.70 46.78% | Perf 3Y | 164.33% |
| Dividend Est. | — | EV/EBITDA | 4.34 | Sales past 3/5Y | 13.85% 29.35% | Gross Margin | 50.52% | Volatility | 1.93% 2.24% | Perf 5Y | 174.08% |
| Dividend TTM | — | EV/Sales | 0.91 | EPS Y/Y TTM | 363.05% | Oper. Margin | 18.39% | ATR (14) | 0.58 | Perf 10Y | 113.20% |
| Dividend Ex-Date | Aug 13, 2021 | Quick Ratio | 0.91 | Sales Y/Y TTM | 22.71% | Profit Margin | 15.58% | RSI (14) | 61.61 | Recom | — |
| Dividend Gr. 3/5Y | — | Current Ratio | 0.91 | EPS Q/Q | 1.52% | SMA20 | 2.48% | Beta | 0.57 | Target Price | 30.00 |
| Payout | 2.10% | Debt/Eq | 0.31 | Sales Q/Q | 1.64% | SMA50 | 4.50% | Rel Volume | 0.80 | Prev Close | 26.01 |
| Employees | 1,068 | LT Debt/Eq | 0.31 | Earnings | Nov 05 | SMA200 | 12.82% | Avg Volume | 796.42K | Price | 25.98 |
| IPO Date | Aug 15, 2013 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 3.69% 22.44% | Net Debt/EBITDA | -7.61 | Volume | 638,018 | Change | -0.12% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-22-26 | Reiterated | RBC Capital | $30 | |
| Jun-26-25 | Initiated | Oppenheimer | Outperform | $25 |
SiriusPoint Ltd. provides multi-line reinsurance and insurance products and services worldwide. It operates in four segments: Global P&C Programs, Global Reinsurance, Global Accident & Health, and London Market Specialty. Global P&C Programs segment offers programs space, by further strengthening its offering to clients and distribution partners globally. , Global Reinsurance segment provides casualty, property, and other specialties, such as proportional and excess of loss, treaty and facultative, aviation and space, marine and energy and, credit to insurance and reinsurance companies, government entities, and other risk bearing vehicles. London Market Specialty segment provides London casualty, energy, property, and marine leaders services. It provides accident and health, property and casualty, aviation and space, credit, surety, marine and energy, and mortgage. It offers medical insurance products, trip cancellation programs, medical management services, and 24/7 emergency medical and travel assistance services. The company was formerly known as Third Point Reinsurance Ltd. and changed its name to SiriusPoint Ltd. in February 2021. SiriusPoint Ltd. was incorporated in 2011 and is headquartered in Pembroke, Bermuda.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,247 | 3,205 | 2,614 | 2,702 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,606 | 1,520 | 1,885 | 1,854 | — | — | — | — | — | |
| Gross Profit | 1,641 | 1,686 | 728 | 848 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 1,043 | 1,144 | 495 | 530 | — | — | — | — | — | |
| Operating Income | 597 | 541 | 233 | 319 | — | — | — | — | — | |
| Interest Expense | 77 | 80 | 70 | 64 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 77 | 80 | 70 | 64 | — | — | — | — | — | |
| Net Income Before Taxes | 597 | 541 | 233 | 319 | — | — | — | — | — | |
| Income Taxes | 91 | 81 | 31 | -45 | — | — | — | — | — | |
| Consolidated Net Income | 506 | 460 | 200 | 355 | — | — | — | — | — | |
| Net Income From Continuing Operations | 506 | 460 | 202 | 364 | — | — | — | — | — | |
| Net Income | 506 | 460 | 200 | 355 | — | — | — | — | — | |
| EPS (Recurring) | 4.15 | 3.81 | 1.06 | 1.93 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 4.15 | 3.81 | 1.06 | 1.93 | — | — | — | — | — | |
| EPS (Diluted) | 4.01 | 3.65 | 1.04 | 1.85 | — | — | — | — | — | |
| EBITDA | 683 | 632 | 315 | 394 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 6.48 | 6.00 | 15.76 | 6.27 | — | — | — | — | — | |
| Price To Sales Ratio | 0.94 | 0.80 | 1.05 | 0.70 | — | — | — | — | — | |
| Gross Margin | 50.54 | 52.61 | 27.85 | 31.38 | — | — | — | — | — | |
| Operating Margin | 18.39 | 16.88 | 8.91 | 11.81 | — | — | — | — | — | |
| Net Margin | 15.58 | 14.35 | 7.65 | 13.14 | — | — | — | — | — | |
| Shares Outstanding | 117 | 117 | 167 | 163 | — | — | — | — | — | |
| Market Capitalization | 3,040 | 2,561 | 2,737 | 1,891 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| de la Gueronniere Rafe | Director | May 08 '25 | Sale | 19.55 | 30,000 | 586,500 | 127,578 | May 16 |
| Loeb Daniel S | Director | Feb 27 '25 | Sale | 13.71 | 4,106,631 | 56,301,911 | 9,428,008 | Feb 28 |
| Cabat Evan | Chief Accounting Officer | Aug 13 '24 | Sale | 14.43 | 2,000 | 28,860 | 33,928 | Aug 14 |
| TAN WEI HAN | Director | Jun 23 '23 | Buy | 8.92 | 17,054 | 152,132 | 18,596 | Jun 26 |
| TAN WEI HAN | Director | Jun 05 '23 | Buy | 9.00 | 1,542 | 13,878 | 1,542 | Jun 07 |
| Loeb Daniel S | Director | May 25 '23 | Buy | 23.75 | 105 | 2,494 | 34,796 | May 30 |
| Loeb Daniel S | Director | May 24 '23 | Buy | 23.74 | 728 | 17,284 | 34,691 | May 24 |
| Loeb Daniel S | Director | May 23 '23 | Buy | 23.68 | 28,463 | 674,015 | 33,963 | May 24 |
| Loeb Daniel S | Director | May 22 '23 | Buy | 23.29 | 5,500 | 128,105 | 5,500 | May 24 |
| Hayes Gretchen A. | Director | Nov 16 '22 | Buy | 5.98 | 4,200 | 25,116 | 103,391 | Nov 17 |
| Malloy Daniel V. | President Global Distribution | Jun 17 '21 | Option Exercise | 10.00 | 36,977 | 369,770 | 774,545 | Jun 17 |
| Malloy Daniel V. | President Global Distribution | Jun 17 '21 | Sale | 10.35 | 36,977 | 382,608 | 737,568 | Jun 17 |
| Malloy Daniel V. | President Global Distribution | Jun 16 '21 | Option Exercise | 10.00 | 45,897 | 458,970 | 783,465 | Jun 17 |
| Malloy Daniel V. | President Global Distribution | Jun 16 '21 | Sale | 10.58 | 45,897 | 485,723 | 737,568 | Jun 17 |
| Malloy Daniel V. | President Global Distribution | Jun 15 '21 | Option Exercise | 10.00 | 27,126 | 271,260 | 764,694 | Jun 17 |